tirzepatide nedir (Zepbound, Mounjaro): Weight Loss, Diabetes, Dosage & Side Effects Mounjaro (Tirzepatide) Nedir? Zararları Ve

Research on 'stepped care' approaches shows that patients who taper to a maintenance dose rather than stopping abruptly experience 40-60% less weight regain over 12 months

Association of inflammatory bowel disease with indicators for childhood antigen and infection exposure

Longitudinal studies in spontaneously hypertensive stroke-prone have demonstrated that gut dysbiosis precedes the onset of hypertension and is marked by shifts in bacterial community structure and altered tryptophan-kynurenine metabolism, implicating microbial pathways in the early development of hypertension and related neurovascular complications (Shi et al., 2022)

Worsening Diabetes-Related Retinopathy For patients with diabetes, theres a potential risk that GLP-1 drugs could worsen retinopathy, a diabetes-related eye condition